A role of macrophages on antiphospholipid syndrome : antigen presenting and mechanisms on thrombosis
A role of macrophages on antiphospholipid syndrome : antigen presenting and mechanisms on thrombosis
批准号:
14570120
负责人:
MATSUURA Eiji
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The oxidative modification of low-density lipoprotein (LDL) in the intima of arteries contributes to the initiation and progression of atherosclerotic lesions. Antiphospholipid syndrome (APS) is an autoimmune disease that causes autoantibody-mediated thrombosis. We have recently found that APS derived-IgG immune complexes with oxidized LDL (oxLDL) and β2-glycoprotein I (β2GPI) were taken up by macrophages and results in forming foam cells.In the present study, we fist analyzed interactions between oxLDL and β2GPI and identified the oxLDL-derived lipid ligands (oxidized lipids) for β2GPI binding. Then, relationship was studied between β2GPI binding to antigen presenting cells, such as macrophages and dendritic cells, and their antigen presenting to β2GPI-specific T cell cones. Further, effect of IgM natural antibodies from hyperlipidemic mice and human subjects on in vitro oxLDL uptake by macrophages were studied, as compared with APS-derived IgG autoantibodies.Antigen presenting was not observed when β2GPI alone was added to culture but was together with liposomes containing negatively charged phospholipids or β2GPI-specific ligands from oxLDL. However, there were not good correlation between binding of β2GPI to macrophages and β2GPI-specific T cell proliferation (i.e., antigen presentation). Antigen processing and presentation may be regulated by trafficking way of lipids that were associated with β2GPI to be uptaken by macrophages. Not like IgG anti-β2GPI autoantibodies, IgM anti-oxLDL natural antibodies prevented oxLDL uptake by macrophages. Macrophages have dual important roles, i.e., not only on lipid metabolism but also on antigen presenting. In the future studies, it must be important to clarify the dual roles of macrophages on natural and autoimmunity.
期刊论文(84)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Wu, R., Matsuura, E.et al.: "Anti-idiotypes to oxidized LDL antibodies in intravenous immunoglobulin preparations-possible immunomodulation of atherosclerosis."Autoimmunity. 36. 91-97 (2003)
Wu, R., Matsuura, E.等人:“静脉内免疫球蛋白制剂中氧化 LDL 抗体的抗独特型 - 可能对动脉粥样硬化进行免疫调节。”自身免疫。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kasahara, J., Matsuura, E.et al.: "Clinical significance of serum oxidized LDL in patients with chronic renal diseases"Nephron Clin.Practice. (in press). (2004)
Kasahara, J., Matsuura, E.等人:“慢性肾病患者血清氧化低密度脂蛋白的临床意义”Nephron Clin.Practice。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
小林和子, 松浦栄次, 他: "血小板と生理活性脂質 章(脂質の酸化と生理活性)執筆 (尾崎由基男、池田康夫、島田和幸、高井義美、丸山征朗編)"金芳堂(東京). 147-160 (2002)
Kazuko Kobayashi、Eiji Matsuura 等:“血小板和生理活性脂质篇(脂质的氧化和生理活性)”(编辑:Yukio Ozaki、Yasuo Ikeda、Kazuyuki Shimada、Yoshimi Takai、Seiro Maruyama)、Konpodo(东京)。 147-160 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Liu, Q., Matsuura, E.et al.: "ω-Carboxyl variants of 7-ketocholesteryl esters are ligands for β2-glycoprotein I and mediate antibody-dependent uptake of oxidized LDL by macrophages"J.Lipid Res.. 43(9). 1486-1495 (2002)
Liu, Q., Matsuura, E.等人:“7-酮胆固醇酯的 ω-羧基变体是 β2-糖蛋白 I 的配体,介导巨噬细胞对氧化 LDL 的抗体依赖性摄取”J.Lipid Res.. 43( 9). 1486-1495 (2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Lopez, D., Matsuura, E.et al.: "IgG autoantibodies against β2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome"Clin.Dev.Immunol.. 10. 223-211 (2
Lopez, D.、Matsuura, E. 等人:“针对 β2-糖蛋白 I 的 IgG 自身抗体与源自氧化低密度脂蛋白的脂质配体复合,与抗磷脂综合征中的动脉血栓形成相关”Clin.Dev.Immunol.. 10 223-211(2.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 59 条
Development of a novel radiological-photo-therapy essential for Theranostics targeting deep lesions
-
批准号:16K15582
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.25万
-
财政年份:2016
-
负责人:MATSUURA Eiji
-
依托单位:
Establishment of Molecular Imaging and Lipidomics Technologies for Early Diagnosis of Atherosclerotic Disease
-
批准号:26253036
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$26.79万
-
财政年份:2014
-
负责人:MATSUURA Eiji
-
依托单位:
Development of a PET imaging system for cancer diagnosis using Zr-89 lableled anti-mesothelin scFv
-
批准号:25670273
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:MATSUURA Eiji
-
依托单位:
Development of targeted therapy of cancer cells with diagnostic imaging through the application of immunoliposomes
-
批准号:23659299
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2011
-
负责人:MATSUURA Eiji
-
依托单位:
Development of targeted medical care (simultaneous diagnostic imaging and therapy) for pathogenic angiogenesis using fibrinolytic metabolites
-
批准号:23390151
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.24万
-
财政年份:2011
-
负责人:MATSUURA Eiji
-
依托单位:
Physiological role of 11-dehydrothromboxane B2 : parameter of platelet activity and aspirin resistance
-
批准号:20590573
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2008
-
负责人:MATSUURA Eiji
-
依托单位:
Pathobiochemical and immunological study on infection-accelerated atherosclerosis and its regulation.
-
批准号:18590296
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.53万
-
财政年份:2006
-
负责人:MATSUURA Eiji
-
依托单位:
海外基金